Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Protagenic Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 113.2K | 537.5K | +424.3K (+374.9%) |
| Value | $106.8K | $205.6K | +$98.8K (+92.4%) |
New holders (2)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advisor Group Holdings, Inc. | 21,414 | $37.5K | 0.00% |
| Eagle Asset Management Inc | 419,324 | – | – |
Sold out (1)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 13,197 | $12.1K |